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AKTIVITI ANTI- Escherichia coli O157:H7 DAN ANTI-OKSIDAN EKSTRAK 
ASETON Piper betle L. DAN FRAKSINYA 
ABSTRAK 
E. coli 0157:H7 merupakan patogen baru yang menyebabkan diarea berdarah 
sehingga mengakibatkan kekejangan abdomen yang teruk, sindrom uremik berdarah 
(HUS), trombositopenik purpura trombotik (TTP) dan juga kematian. Terdapat 
laporan menyatakan bahawa penggunaan antibiotik dalam rawatan boleh 
meningkatkan risiko pesakit mengalami HUS yang boleh membawa maut. Oleh 
sebab itu, hasil tumbuhan boleh dijadikan sumber alternatif dalam pencegahan 
transmisi dan infeksi patogen tersebut di kalangan populasi umum. Melalui asai 
pembauran cakera, daripada dua puluh empat ekstrak yang diperolehi daripada lapan 
tumbuhan Malaysia, ekstrak aseton P. betle memberikan zon perencatan yang 
terbesar pada 20.56 ± 0.19 mm. Ekstrak ini juga berhubung kait dengan kandungan 
jumlah fenolik (TPC) di mana ia menunjukkan jumlah yang tertinggi di antara 
ekstrak yang diuji pada 430.69 ± 47.50 µg GAE/ mg ekstrak seperti yang telah 
ditentukan oleh kaedah Folin-Ciocalteu. Melalui asai pencairan mikro, ekstrak aseton 
P. betle memberi  nilai MIC terendah iaitu pada 500 µg/ ml dan MBC pada 2000 µg/ 
ml terhadap E. coli O157:H7. Fraksinasi berpandu bio-asai telah dibuat dan sistem 
larutan klorofom: methanol pada nisbah 19:1 dipilih untuk fraksinasi ekstrak aseton. 
Fraksinasi dijalankan menggunakan penyediaan kromatografi lapisan nipis (TLC) 
dan kesemua fraksi yang terkumpul diuji untuk aktiviti antibakteria, TPC dan aktiviti 
antioksidan. Fraksi 5 memberi nilai MIC paling rendah pada 500 µg/ ml, kandungan 
fenolik yang tinggi (398.25 ± 7.74 GAE/ mg ekstrak) dan aktiviti anti-oksidan yang 
tinggi melalui asai DPPH (80.43 ± 0.71%). Aktiviti antibakteria fraksi 5 menurun 
semasa penyimpanan menyebabkan ia dicampur dengan fraksi 6 dan 7 (dikenali 
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dengan fraksi A) untuk menjadi lebih stabil. Nilai MIC fraksi A terhadap E. coli 
O157: H7 adalah lebih rendah pada 250 µg/ ml tetapi nilai MBC meningkat kepada > 
2000 µg/ ml. Ekstrak aseton dan fraksi A diuji untuk induksi morfologi dan 
perubahan ultrastruktur E. coli O157:H7 pada fasa eksponen di dalam kultur 
kelompok. Berdasarkan pemerhatian melalui mikroskop elektron imbasan dan 
transmisi, kerosakan sel oleh fraksi A adalah kurang dibandingkan kerosakan sel 
yang disebabkan oleh ekstrak aseton pada 2000 µg/ ml. Asai toksisiti menggunakan 
anak udang (Artemia salina) menunjukkan nilai LC50 bagi ekstrak adalah 500 µg/ ml 
dan fraksi A adalah >1000 µg/ ml. Kromatografi gas- spektrometri jisim (GC-MS) 
untuk fraksi A menunjukkan tiga kompaun fenolik utama, Chavicol, 
Hydroxychavicol and Chavibetol yang mungkin menyumbang kepada aktiviti 
antibakteria. Daripada kajian ini, boleh dirumuskan bahawa fraksi A pada 250 µg/ ml 
ke 2000 µg/ ml dan ekstrak aseton P. betle sehingga 500 µg/ ml hanya bersifat 
bakteriostatik terhadap E. coli O157:H7 tetapi ekstrak aseton pada 2000 µg/ ml 
bersifat bakterisidal. Ekstrak aseton adalah toksik pada kepekatan bakterisidal, 










ANTI-Escherichia coli O157:H7 AND ANTI-OXIDANT ACTIVITIES OF 
ACETONE EXTRACT OF Piper betle L. AND ITS FRACTIONS 
ABSTRACT 
 E. coli 0157:H7 is a newly emerging pathogen that cause bloody diarrhoea to 
severe abdominal cramps, haemolytic uremic syndrome (HUS), thrombotic 
thrombocytopenic purpura and even death.  There are reports that antibiotic 
treatment increases the risk of patients developing fatal HUS. Therefore plant 
products could be an alternative source for prevention of transmission and hence 
infection of the pathogen among the general populations. By disc diffusion assay, out 
of twenty four extracts from eight Malaysian plants, acetone extract of P. betle 
inhibited E. coli 0157:H7 strongly giving the largest inhibition zone at 20.56 ± 0.19 
mm.  This correlates strongly with  its total phenolic content (TPC) which was the 
highest among those tested at 430.69 ± 47.50 µg GAE/ mg as determined  by Folin-
Ciocalteu method.  By microdilution assay, acetone extract of P. betle gave the 
lowest MIC at 500 µg/ ml and MBC at 2000 µg/ ml against E. coli O157:H7.  Bio-
assay guided fractionation of acetone extract was done using a solvent system of 
chloroform: methanol at a ratio of 19:1. Fractionation was done by preparative TLC 
and the fractions collected were all assessed for antibacterial activity, TPC and AOA. 
Fraction 5 gave the lowest MIC against E. coli 0157:H7 at 500 µg/ ml, high TPC 
(398.25 ± 7.74) as well as high anti-oxidant activity as assessed by DPPH (80.43 ± 0. 
71 %). Upon storage, the antibacterial activity of fraction 5 was reduced. It was 
subsequently mixed with fraction 6 and 7 (now known as Fraction A) which was 
more stable. The MIC for fraction A against E. coli O157:H7 was much lower at 250 
µg/ml but its MBC increased to >2000 µg/ ml. Acetone extract of P. betle and 
fraction A were also tested for induction of morphological and ultrastructural 
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changes of E. coli O157:H7 at exponential phase in a batch culture.  Based on 
observation by SEM and TEM, cellular damage by fraction A was not as severe as 
that given by acetone extract, both at 2000 µg/ml. Toxicity assay using brine shrimp 
(Artemia salina) showed LC50 of acetone extract was 500 µg/ ml and fraction A was 
>1000 µg/ ml. Gas chromatography- mass spectrometry (GC-MS) of the fraction 
revealed three major phenolic compounds, Chavicol, Hydroxychavicol and 
Chavibetol which may contribute to the antibacterial activity.  From this study, it can 
be concluded that fraction A at 250 µg/ ml to 2000 µg/ ml and acetone extract up to 
500 µg/ ml were only bacteriostatic towards  E. coli O157:H7 meanwhile acetone 
extract was bactericidal at 2000 µg/ ml. Acetone extract was toxic at bactericidal 







Escherichia coli O157:H7 is an emerging pathogen that cause significant 
important effects to human health. Most of E. coli is a commensal found in intestinal 
tracts but the strain used in the study was a subset of the pathogenic E. coli which has 
virulence factors that differentiate it from the normal E. coli. E. coli O157:H7 was 
known as enterohaemorrhagic E. coli (EHEC) and Shiga toxin producing E. coli 
(STEC) (Centre for Food Security and Public Health, 2009). It was identified as an 
etiological agent for diarrhoea (Aboaba et al., 2006) and has been the cause of many 
outbreak related to food contamination. Although there is no outbreak by this 
pathogen occurred in Malaysia, the prevalence assessed by some researchers showed 
the existence of it in Malaysian food products such as beef (Frederick, 2011). 
However, information regarding E. coli O157:H7 in Malaysia is scanty thus leading 
to the use of E. coli O157:H7 in this study. 
Persons infected with E. coli O157:H7 showed the effects from asymptomatic 
to lethal. The most prominent clinical features of E. coli O157:H7 infections are 
bloody diarrhoea and haemolytic uremic syndrome (HUS) (Keene et al., 1994). The 
symptom of bloody diarrhoea usually disappear in most patients but the elderly or 
younger patient infected tend to progress to HUS (Nataro and Kaper, 1998). The 
illness likely to become severe in patients who is very young or very old.  
The treatment of EHEC infection is limited to supportive therapy as there is 
no specific antibiotic or vaccines available treating the EHEC infection. The usage of 
antibiotic in patient with this infection showed no alteration of the disease outcome 
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(Nataro and Kaper, 1998). Nevertheless, some studies showed the usage of antibiotic 
is necessary depending on the patient’s presentation (Collins and Green, 2010). 
Although it is susceptible to many antibiotics, some strain also showed resistant 
toward some of the antibiotic used (Frederick, 2011).  
Prevention and treatment without major side effect can be done as long as 
suitable substances were found. With the emergence of new resistant strains of the 
bacteria and treatment failure of some modern drugs, alternative approaches were 
done to search for a new plant-based medicine. Complication of the antibiotics used 
for treating EHEC infection lead to this study to find an alternative to prevent its 
transmission.  
Plants have been used for treating many diseases and infections by many 
traditional practices. They have ability to synthesize aromatic substances including 
antimicrobial phytochemical such as phenolic and polyphenols (Cowan, 1999). 
Phenolic compounds apart from being identified as having the antibacterial property 
also act as an antioxidant which is important in preventing the oxidative stress known 
to be related with the aetiology of human disease (Rathee et al., 2006). This 
substances were used and exploited by pharmaceutical industries as the source of 
their drugs (Aboaba et al., 2006). With the basis of plant has been used as medicine 
since ancient time, the study was aimed to search for potential medicinal plant found 
widely in Malaysia. Jamal et al. (2010) showed that, Malaysian plants contain 
valuable compounds such as phenol and thus it has potential to be used as alternative 
treatment. In this study, several Malaysian plants will be screened for their anti- E. 
coli O157:H7 activity and the selected plant extract will be assessed in several assays 
to support the fact that it has the potential as a new alternative source to treat and 
prevent the transmission of E. coli O157:H7. 
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1.2 Problem statement 
 There is no specific treatment for E. coli O157:H7 as the antibiotics used to 
treat patients infected with the pathogen increased the risk of patient developing 
HUS. The study was carried out to provide new information on the phenolic content, 
antioxidant activity and antibacterial activity against E. coli O157:H7 of selected 
Malaysian plants. The usage of plant as alternative treatment for E. coli O157:H7 is 
suitable because of the fewer side effects and availability. Besides treatment, the 
plant can be used to prevent the transmission of E. coli O157:H7 by external usage. 
1.3 Research Objectives 
The objectives of this study were: 
1. To determine anti-Escherichia coli O157:H7 activity of twenty four 
extracts derived from eight selected Malaysian plants  
2. To determine and compare the total phenolic content (TPC) and anti-
oxidant activities (AOA) of the plant extracts that exhibited anti-E. coli 
O157:H7 activity. 
3. To assess the induction of morphological and ultra-structural changes by 
potential fraction on E. coli O157:H7 in a batch culture under SEM and 
TEM. 
4. To determine the toxic activity of selected fraction and extract by brine 
shrimp toxicity assay 
5. To determine the compounds present in the active fraction using Gas 






2.1  Medicinal plants 
 Medicinal plants refer to plants which exhibit medicinal potential. In 
Malaysia, the diverse flora was diverse making it excellent to screen for different 
biological activity attributed by their secondary metabolites (Jamal et al., 2010). 
Information on their medicinal uses usually derived from various knowledge of 
traditional medicine and this forms the basis for most of drug discovery (Fabricant 
and Farnsworth, 2001).    
 It is estimated that 80% of the population in developing countries depend on 
medicinal plants for their health requirements (Milow et al., 2011; Patra et al., 2009). 
The knowledge of the medicinal plant has played a role in a new drug discovery. 
These were shown in a report by Saklani and Kutty (2008) that twenty six plant 
based drugs were approved or launched between 2000 to 2006, including a drug 
named polyphenon E (Veregen) in a form of ointment. The main compound is 
polyphenol (catechin) extracted from green tea and used to treat genital and perianal 
warts. 
 In this study, several plants were selected for screening of anti-bacterial and 
anti-oxidant activity. The plants were used as traditional medicine and known 
locally. Table 3.1 showed the list of the plants and its traditional used. From the list, 
some plants were used for other purposes apart from being used as medicine. For 
examples, Samanea saman, which is known as rain tree, have been used as source of 
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timber and its wood have been crafted for sale to the tourists (Staples and Elevitch, 
2006) and Pelthopharum pterocarpum known to be ornamental plant along the road 
side and park. The bark of the plant has been utilized for making furniture and source 
of fire wood (Ong, H.C., 2004). In this study, Piper betle have been the most 
potential plant for having the anti-E. coli O157:H7 activity thus more review of the 
plant in section 2.7. 
2.2 Antibacterial agent 
An antibacterial agent is a compound that is natural, synthetic or semi 
synthetic and active against bacteria (Vasanthakumari, 2007). Antibiotic which was 
used frequently for treating the bacterial infection was a natural product or a 
derivative from it. The actions of the antibiotic towards the bacteria are listed as 
below:  
(a) Inhibit cell wall synthesis by preventing the synthesis of peptidoglycan which 
is a major component of Gram positive bacterial cell wall, e.g., Penicillin. 
(b) Inhibit protein synthesis by inhibiting the process of transcription and 
translation, e.g., Chloramphenicol. 
(c) Inhibit nucleic acid synthesis by inhibiting the DNA replication and 
translation in the microorganisms, e.g., Metronidazole. 
(d) Damage the cell membrane by attaching to the membranes phospholipid 
causing problem of membrane permeability, e.g., Polimyxine B. 
(e) Inhibit specific enzyme systems by resembling the metabolite such as para-
amino-benzoic acid (PABA) which is attached to the enzyme responsible for 




The usage of antibacterial agents however is based on a number of factors 
including pathogen identity, infection site, the interaction of the agent and the side 
effect it cause to the patient, pharmacokinetics and pharmacodynamics of the agent, 
cost and its administration (Hessen and Kaye, 2004). Current therapy used the 
antibacterial agents by single or in combination to demonstrate greater activity. 
Although it is widely used in current medical practice, there are still issues arising 
from the usage. The side effects such as renal impairment may occur as a result of 
the drug accumulation which then relates to its toxicity (Hessen and Kaye, 2004). 
Alternatively, the plants have been used widely in traditional medicine thus offering 
an option to aid in the treatment of diseases cause by pathogens. 
 
2.3 Antibacterial activity of medicinal plants 
Medicinal plants have been known to exhibit a lot of pharmacological 
activity. The natural mechanism of plants against microorganism, insect and other 
organisms and their ability to produce limitless substances has given the researchers 
the opportunity to explore their use as anti-microbial agents. In addition, the side 
effects related to the use of synthetic drugs (Jamal et al., 2010) and the availability of 
few pharmaceutical dispenses use for antimicrobial activity (Cowan, 1999) also 
stimulate many researchers searching for new anti-infections agent from natural 
resources (Rios and Recio, 2005). The activity exhibited by plants was contributed 
by the compound they synthesized. Table 2.1 showed some medicinal plants that 
exhibited the antibacterial activity and table 2.2 shows the phytochemical compounds 




  Table 2.1: Examples of medicinal plants with antibacterial activity. 
Plants Bacterial Species References 
Vaccinium macrocarpon Listeria monocytogenes, Salmonella typhimurium, 
Staphylococcus aureus 
Wu et al. (2008) 
Samanea saman  S. aureus and Escherichia coli Jagessar et al. (2011) 
Litsea glutinosa, Vitex peduncularis     
and  Elephantopus scaber 
S. aureus, Pseudomonas aeruginosa, Proteus mirabilis, 
Enterococcus faecalis and E. coli  
Prusti et al. (2008) 
Curcuma manga P. aeruginosa, Bacillus subtilis and S. aureus Philip et al. (2009) 
Ficus racemosa, Vitex negundo,     
Ocimum basilicum and Etlingera 
elatior 
Klebsiella pneumonia, S. aureus, Salmonella typhi,    
Proteus vulgaris and P. aeruginosa 
Renisheya et al. 
(2011) 
Derris trifoliata Helicobacter pylori  Uyub et al. (2010) 
Bupleurum falcatu and Stachys 
pubescens 
S. aureus, L. monocytogenes, Streptococcus pneumonia,     
P. aeruginosa, K. pneumonia, E. coli and S. typhi 




 Cont. Table 2.1 
Plants Bacterial Species References 
Zingiber zerumbet  Vibrio parahemolyticus Kader et al. (2011) 
Coleus amboinicus Methicillin-Resistant S. aureus (MRSA) Sahgal et al. (2009) 
Marrubium vulgare Mycobacterium tuberculosis Buzayan and El-
Garbulli, (2012) 
Phyllanthus amarus S. aureus, Serratia marcescens, E. coli, Enterobacter 
sp., Streptococcus fecalis, K. pneumonia, P. mirabilis 










Table 2.2: Major classes of antimicrobial compounds from plants (Cowan, 1999). 
Class Subclass Example (s) Mechanism 
Phenolics Simple 
phenols 
Catechols Substrate deprivation 
  Epicatechin Membrane disruption 
 Quinones Hypericin Inactivate enzymes 
 Flavonoids Chrysin Bind to adhesins 
 Flavones Abyssinone Inactivate ezymes 
 Tannins Ellagitannin Membrane disruption 
   Bind to protein, adhesins 
 Coumarins Warfarin Interact with eukaryotic DNA 
Terpenoids  Capsaicin Membrane disruption 
Alkaloids  Berberine Intercalate into cell wall / DNA 





Block viral fusion or adsorption 
















2.4 Escherichia coli O157:H7  
2.4.1 E. coli O157:H7 discovery 
The first isolate of this serotype was from a sporadic case of haemorrhagic 
colitis in 1975 known as non-invasive or non-toxigenic by a standard test conducted 
(Riley et al., 1983). It was not recognized as etiologic of foodborne illness just until 
the report of two outbreaks of gastrointestinal illness which occurred in 1982 
associated with this pathogen (Riley et al., 1983). Since then, it caused many major 
outbreaks related food-borne infections and caused a serious concern in public 
health. 
2.4.2 Characteristics 
E. coli O157:H7, similar to other E. coli, is a Gram negative and rod-shape 
bacterium but differentiated from other E. coli strains by its serogroups, 
pathogenicity and virulence (Nataro and Kaper, 1998). The pathogen expresses 
somatic (O) antigen 157 and flagella (H) antigen 7 and cannot produce β-
glucoronidase (Lim et al., 2010). The biochemical reactions of E. coli O157:H7 are 
the same as typical E. coli except for it does not ferment sorbitol thus yielding 
colourless colonies on the Sorbitol MacConkey agar (SMAC) (March and Ratnam, 
1986). The strain also shows no haemolytic reaction on sheep and rabbit blood agar 
(Wells et al., 1983).  
2.4.3 Pathogenicity 
E. coli O157:H7 cause bloody diarrhoea (haemorrhagic)  to severe abdominal 
cramps, HUS, thrombotic thrombocytopenic purpura and even death (Griffin et al., 
1988; Keene et al., 1994). This pathogen produces several virulent factors. The most 
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important virulent factors of this pathogen causing death and other symptoms in 
patients infected are Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2) (Baker et al., 
2007). The toxin produced was identical at the genetic and protein levels to the Stx 
produced by Shigella dysentariae hence the alternative name for the pathogen is 
STEC (Shiga toxin-producing E. coli) (Nataro and Kaper, 1998). The ability to 
produce Stxs makes them important as the toxins have been linked to the HUS that 
can lead to renal failure (Mohawk and O’Brien, 2011). Beside STEC, the strain was 
known to cause hemorrhagic colitis which led them to be named as 
enterohaemorrhagic E. coli or EHEC (Centre for Food Security and Public Health, 
2009). 
The pathogenesis of E. coli O157:H7 was established in a model of E. coli 
O157:H7 oral infection of BALB/c mice (Mohawk et al., 2010) whereby after the 
pathogen was ingested, it will colonize the cecum and allowing the Stx2 to enter the 
blood stream through the colonization site in the gastrointestinal tract. The toxins 
travel to the kidney and altered the kidney function hence causing HUS. Cattle which 
are major reservoirs of E. coli O157:H7 show no symptom although they are 
infected. Cattles are not sensitive to shiga toxins and have different site for 
colonization of the pathogens compared to the human thus making them tolerant 
hosts with continuous transmission of the pathogen (Nguyen and Sperandio, 2012).  
Apart from the two major virulence factors (Stx1 and Stx 2 toxins), four other 
factors may contribute to the virulence of this pathogen. First, enterohemolysin 
which cause the erythrocyte to hemolyse releasing the source of iron needed for 
bacterial growth.  Second, the intestinal adherence factor known as intimin which 
help the pathogen to attach to the intestinal wall causing lesion. Third, an iron 
transport system which is a special system possessed by E. coli O157:H7 that helps 
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them using the product of haemolysed erythrocyte as the source of iron and lastly, 
the O157 lipopolysaccharide (O157 LPS) which help to boost the cytotoxicity of the 
Stx toxins on human vascular endothelial cells (Nataro and Kaper, 1998). 
 
2.4.4 Epidemiology and Transmission 
Since the outbreak of E. coli O157:H7 in 1982 (Riley et al., 1983), several 
other outbreaks have been reported till that recently occurred in USA related to 
organic spinach and spring mix blend in December 2012 (Centre for Disease Control 
and Prevention, 2013). Along with the outbreak and surveillance study conducted, 
the transmissions of infection were identified and established.  
Report by World Health organization in 1997, since 1992 until 1997, 42 cases 
of outbreak were reported out of which 25 cases were  foodborne, 10 cases by person 
to person contact and 2 cases by contact with animals. The transmission of 90 
outbreaks occurred in UK, Denmark, Norway, Finland, USA, Canada and Japan 
between 1982 and 2006 confirmed that the source was from food (42.2%), dairy 
products (12.2%), animal contacts (7.8%), water (6.7%), environmental (2.2%) and 
unknown (28.9%) (Pennington, 2010). Thirteen outbreaks reported by CDC (2013) 
within the period of 2006 until 2012 were linked to transmission by fresh spinach in 
2006, frozen beef ground patties and pizza in 2007, ground beef in 2008, pre-
packaged cookie dough and beef in 2009, beef and cheese in 2010, Romaine lettuce, 
Lebanon bologna and in shell hazelnuts in 2011 and by organic spinach in 2012. All 
of the cases occurred in the USA.  
In Asia, E. coli O157:H7 have been isolated in Japan, India and China (Radu 
et al., 1998) but the major outbreaks only occurred in Japan with 9,451 cases and 
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twelve deaths. The transmission was caused by food including white radish sprouts, 
salad, seafood sauce and raw beef (WHO, 1997). Another outbreak with death 
occurred in Jiangsu Province, China in 1999 where ninety five patients infected with 
E. coli O157:H7 developed acute renal failure and 87% fatality rate (Centre for 
Health Protection, 2010). 
In Malaysia, most of the foodborne outbreaks are caused by Salmonella sp., 
Shigella sp., Salmonella typhi and Vibrio sp. (FAO/WHO, 2004). None of the 
outbreak was due to E. coli O157:H7 but, the pathogen have been isolated from beef 
(Radu et al., 1998; Sahilah et al., 2010), organic vegetables and chicken marketed in 
Malaysia (Chang et al., 2013).  Although a large number of foodborne disease 
incidence have been reported in Malaysia, there is still less effort to show the impact 
and its importance, therefore the true incidence of foodborne outbreaks occurred is 
unknown (Lim, 2002). 
Most of the outbreaks of E. coli O157: H7 infections occurred were linked 
with the consumption of contaminated food by the pathogen. Several factors 
associated with the infection include dose of infection, source of food, food 
processing and probably the environment that supports the survival of the pathogen. 
Beef was associated with most of the contaminated food occurred in the outbreak and 
source of isolates.  The animals, especially ruminants are reservoir hosts for E. coli 
O157:H7. 




 CFU) were required to colonize the ruminants such as mature cattle and sheep. 
Along with the dose of infection, the susceptibility of the animals toward the 
pathogen was also taken into consideration so that it will sustain the population. The 
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animal infected with the pathogen can transmit the pathogen by shedding it in their 
faeces (Cornick and Helgerson, 2004). Human could be infected by the pathogen by 
the consumption of the food contaminated directly from the source or by 
contaminated surface.  High infectious dose is required to infect the animals, while a 
lower dose is required to cause infection in humans.  It was reported that the 
infectious dose for human can be as low as 50 to 700 organisms (Tilden et al., 1996, 
Tuttle et al., 1999). 
2.4.5 Treatment and prevention 
Treatment of E. coli O157: H7 infection usually involves the patient’s 
appearance and the severity of the infection. In less severe cases, the management 
include resting and replacement of fluid and electrolyte where else surgery may be 
considered in critically ill patients with abdominal pain (Collins and Green, 2010). 
Antibiotics are   used in septic patients but for E. coli O157:H7 infection, the use of 
antibiotics is not established as no clinical studies have proven that it is effective in 
reducing the infection and duration of bloody diarrhoea (Collins and Green, 2010). 
Several mechanisms have been proposed by Kimmit et al. (2000) explaining why the 
use of antibiotics in treating E. coli O157:H7 infection was not effective. The 
antibiotics may kill the intestinal normal flora leading to the overgrowth of E. coli if 
it was resistant to the antibiotics. Another reason is that antibiotics may cause the E. 
coli O157:H7 to lyse and release the Shiga toxins or induce the expression of Stx 
genes. 
Although the issue regarding the use of antibiotic in E. coli O157:H7 
treatment is controversial, Safdar et al. (2002) using meta-analysis studies showed no 
association between the usage of antibiotic with the risk of  developing fatal HUS. It 
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is contrary with another cohort study by Wong et al.  (2000) which reported that the 
antibiotic treatment in children infected by the pathogen increase the risk of HUS. 
The antibiotic frequently used for the treatment of E. coli O157:H7 infection is 
Trimethoprim-sulfamethoxazole and Fosfomycin (Safdar et al., 2002). 
Beside treatment, prevention was done to eradicate the E. coli O157:H7 
infection. Most of the practices have been applied and some are still in research or 
have not been established. For example, microbial intervention procedure was done 
at slaughter houses such as hot water washes and steam pasteurization (Berry and 
Wells, 2010), actually helps in reducing the number of   bacteria from the cattle 
carcasses. Disinfection to kill or inactivate the organism can be done using several 
disinfectants such as 70% ethanol, glutaraldehyde, and iodine-based disinfectants, 
moist heat (121
o
C, 15 minutes), dry heat (160-170
o
C, 60 minutes) and for food, it is 
safe to cook them at a minimum temperature of 71
o
C (CFSPH, 2009). Another 
recommendation to reduce the infection is by drinking the pasteurized milk and juice, 
wash fruits and vegetable before eating, wash hands after touching animals and avoid 
swimming in lakes which are also used by cattles (Buchanan and Doyle, 1997). 
2.4.6 Anti- E. coli O157:H7 from plant extract. 
It is known that plants have been widely used in traditional medicine. The 
plants can be consumed in a large quantity by human with fewer side effects 
compared to the existing chemical anti-bacterial agents. Some plants are used as anti-
bacterial agent to treat the infection and this lead some researcher to conduct a study 




Table 2.3: Plants with anti- E. coli O157:H7 activity 
Plant Local name References 









Stonsaovapak et al.   (2000) 
 
Vaccinium macrocarpon Kranberi Wu et al. (2008) 
Brassica oleracea. Kailan  Hafidh et al. (2011) 
Ascophyllum nodosum Rumpai laut Wang et al. (2009) 
Quercus infectoria Manjakani Suwalak and Voruthikunchai, (2009) 













2.5 Phenolic compound 
Phenolic compound is a substance containing one or more aromatic rings 
bearing one or more hydroxyl groups (Harborne, 1973).  The simple phenols or 
polyphenols are grouped based on the phenol unit present in the molecule 
(Khoddami et al., 2013) which means a simple phenol is a phenol with a substitution 
pattern of the benzene ring and the functional group is hydroxyl while polyphenols 
refer to more than one phenolic hydroxyl group attached to one or more benzene 
rings (Vermerris and Nicholson, 2006). Figure 2.1 shows some molecular structure 
of the phenols. Harborne and Simmonds (1964) classified the phenolic compounds 
















Table 2.4: Classification of phenolic compounds.  
Structure Class 
C6 Simple phenolics 
C6-C1 Phenolic acids and related compounds 
C6- C2 Acetophenones and phenylacetics acids 
C6- C3 Cinnamic acids, Cinnamyl aldehydes, 
Cinnamyl alcohols 
C6-C3 Coumarins, isocoumarins and chromones 








C6 – C1- C6, C6,- C2- C6 Benzophenones,Xanthones, Stilbenes 
C6, C10, C14 Quinones 
C18 Betacyanins 
Lignans, neolignans Dimers or Oligomers 
Lignin Polymers 








Phenolic compounds are essential metabolites for plant growth, reproduction 
and serve in plant defence mechanisms against pathogens (Mujica et al., 2009). 
Harborne (1973) reported phenolic compounds were one of the compounds included 
as phytoalexins (higher plant product of metabolism in response to microbial attack) 
and preinfective substances (secondary constituents occurred naturally which is 
important in imparting disease resistance to plants). 
They also contribute to the properties of food mainly vegetal origin in term of 
the quality, nutritional value, colour, taste, aroma and flavour (Mujica et al., 2009; 
Memmune et al., 2009). Plant phenolics, in general, are highly effective free radical 
scavengers and antioxidants (Tung et al., 2007). Their structure determines 
antioxidant activity and this was referred to as structure-activity relationship (SAR) 
(Balasundram et al., 2006). The fact was supported by studies showing good 
correlation between the phenolic content of plants and their antioxidant activity 
(Dasgupta and De, 2004; Cai et al., 2004).  
Phenolic compounds also exhibit anti-bacterial, anti-inflammatory, anti-
mutagenic and anti-nociceptive activities (Thèriault et al., 2006; Güvenç et al., 2010; 
Maddox et al., 2010; Muthuraman et al., 2011).  
2.6 Anti-oxidant activity (AOA) 
Oxidative stress occurs in response to the free radical which try to take 
electron from the body causing damage to the human cells related to human diseases 
such as chronic inflammation, atherosclerosis, degenerative disease  and certain type 
of cancer (Karadag et al., 2009; Kumar, 2012). Anti-oxidant activity indicates the 
capability of the anti-oxidants to counteract the oxidative stress as they intercept and 
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react with the free radicals and inhibit the oxidation process (Wright et al., 2001; 
Tirzitis and Bartosz, 2010). A number of mechanisms can be served by anti-oxidants 
as preventive agents. These include acting as physical barriers by preventing the 
generation and access of reactive oxygen species (ROS) to the crucial biological site, 
trapping the energy and electrons, neutralizing or diverting ROS by acting as 
catalytic system, inactivating or binding thus preventing the generation of ROS and 
acting as chain-breaking anti-oxidants which scavenge and destroy ROS (Wright et 
al., 2001; Karadag et al., 2009).  
Anti-oxidants present in cells are known as endogenous anti-oxidants and 
function to neutralize the oxidative stress occurred in the body. Anti-oxidants from 
the dietary intake are needed to assisst the endogenous antioxidants for acting their 
role efficiently (Pham-Huy et al., 2008). Anti-oxidants are abundant in fruits and 
vegetables, tea, cereal, aromatic plants and others existing as natural anti-oxidants 
with some of the compounds with a well-known source such as tocopherols and 
ascorbic acids and some are too complex such as plant phenols (Dimitrios, 2006; 
Hamid et al., 2010).  It is very difficult to classify the anti-oxidants as their 
molecular constituents are heteregenous. Table 2.5 shows classes of the anti-oxidants 








Table 2.5: Various classes of anti-oxidants.  
Class Example 
Vitamins Retinol (Vitamin A), Vitamin E, 
Vitamin C, Nicotinamide (Vitamin B3), 
Riboflavin and Niacin 
Fats and Lipids PUFAs (Omega 3 and 6) 
Amino acids Taurine, Glutamine, L-Arginine, Histidine, Glycine, Thiols, 
N- Acetyl Cysteine,  
Peptides Carnosine, Gamma- glutamyl cysteinyl glycine (GSH) 
Proteins Albumin, Thioredoxin, Lactoferrin, Transferrin, Bilirubin, 
Ceruloplasmin 
Plant derived products Phenols (Tocopherols and tocotrienols), polyphenols, 
flavonoids, Carotenoids, Biochanin A, Glucosinolates, 
Allicin 
Minerals Zinc, copper, iron, Selenium, toxic metals,  














2.7 Piper betle L. (Sirih) 
2.7.1 Taxonomy  
Family Piperaceae comprises approximately 5 genera and 1400 species. The 
most representative are from genera Piper and Peperomia with 700 and 600 species, 
respectively (Vaghasiya et al., 2007). The Piper species are scandent herbs, shrubs or 
infrequently trees and have high commercial, economical and medicinal importance 
(Parmar et al., 1997). Piper betel Linn are extensively grown in India, Sri Lanka, 
Malaysia, Thailand, Taiwan and other Southeast Asian countries with its common 
names known as betel (in English), paan (in Indian), phlu (in Thai) and Sirih (in 
Bahasa Indonesia) (Suppakul et al., 2006; Datta et al., 2011). Taxonomy of P. betle 
is as follows (United States of Agricultural Department [USDA]): 
  
Kingdom: : Plantae 
Subkingdom: : Tracheobionta 
Superdivision: : Spermatophyta 
Division: : Magnoliophyta 
Class: : Magnoliopsida 
Subclass: : Magnoliidae 
Order: : Piperales 
Family: : Piperaceae 
Genus: : Piper L. 







Figure 2.2: Piper betle tree 
 
 








In traditional health system, the values of the P. betle L. are recognized and it 
has many uses. Apart from being traditionally used for chewing purposes with other 
condiments (Arambewela et al., 2005a), betel leaves are also used in poultices to 
relieve stomach pains, antiseptic, treat ulcers, wounds and burns, detoxication 
(Joseph et al., 2009; Kumar et al., 2010).  Its light yellow aromatic essential oil with 
sharp burning is valued as being aromatic, antiseptic, treating respiratory or digestive 
problems and even as aphrodisiac (Joseph et al., 2009; Kumar et al., 2010). The roots 
are believed to be contraceptive for women and favouritely chewed by singer for 
voice improvement while the flowers are used as ingredients in the betel quid and 
fruit for cough (Ghosh and Bhattacharya, 2005; Nagori et al., 2011). 
2.7.3  Chemical constituents 
A number of studies have reported on the chemical constituents of P. betle L. 
A review paper by Parmar et al. (1997) classified nearly 600 chemical constituents 
belonging to Piper species within the period of 1907 to June 1996. Among them, 
compounds which were detected in the P. betle belonging to different classes of 
bioactive compounds such as alkaloids/amides (Piperine and Piperlonguminine), 
propenylphenols (Allylpyrocatechol diacetate, Chavibetol, Chavicol, Eugenol, 
Hydroxychavicol, Isoeugenol and Safrole), terpenes (Camphene, β-Caryophyllene, ρ-
Cymene, Limonene, Myrcene, β–Pinene, α-Terpinene and α-Terpineol acetate), 
steroids (Sitosterol, β-Sitosteryl palmitate, γ-Sitosterol), Most of the compounds 
identified were found in the leaves of P. betle. The leaf of P. betle also consist of 
water, proteins, carbohydrates, minerals, fat, fibre, essential oil, tannin, alkaloid, 
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vitamin C, vitamin A, Thiamine, Riboflavin, minerals such as calcium, iron, iodine, 
phosphorus and potassium (Pradhan et al., 2013).  
Eugenol, safrole, quarcetin, β-sitosterol, Piperine, Piperlonguminine, 
Linalool, isoeugenol, flavones, α-pinene and β-caryophyllene are found in the flower, 
stem and roots of P. betle (Ghosh and Bhattacharya, 2005; Nagori et al., 2011). 
Apart from the plant part, betel oil contains eugenol, caryophyllene, 3-benzodioxole 
and 5-(2-propenyl) (Caburian and Osi, 2010). Table 2.6 shows some of the activity 
exhibited by the compounds of P. betle. 
Table 2.6:  Biological activities of some chemical constituents of P. betle extracts  
(Kumar et al., 2010) 
  
Chemical constituent Biological activity 
Hydroxychavicol Antidiabetic, Cytokine production in Th cells, 
inhibits platelet aggregation, chemoprotective 
Allypyrocatechol Healing gastric ulcer, anti-infalmmatory 
Chavibetol Radioprotective 
Piperbetol, Piperol A,  
Piperol B, Methylpiperbetol 
Selectively inhibit platelet aggregation 
 
2.7.4 Pharmacological activities of Piper betle L. 
The traditional usage and the constituents of P. betle have been pointed out 
previously and its pharmacological activity is listed in table 2.7.
